Przejdź do zawartości
Merck

S2151000

Sulfanilamide

European Pharmacopoeia (EP) Reference Standard

Synonim(y):

p-Aminobenzenesulfonamide

Slide 1 of 1
Zaloguj się, aby wyświetlić ceny organizacyjne i kontraktowe.

Wybierz wielkość

100 MG

670,00 zł

670,00 zł

Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności
Zamów zamówienie zbiorcze

Informacje o tej pozycji

Wzór liniowy:
H2NC6H4SO2NH2
Numer CAS:
63-74-1
Masa cząsteczkowa:
172.20
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
329824507
MDL number:
MFCD00007939
Beilstein/REAXYS Number:
511852

Kluczowe dokumenty

Wyświetl całą dokumentację

Przejdź do

Pomoc techniczna
Potrzebujesz pomocy? Nasz zespół doświadczonych naukowców chętnie Ci pomoże.
Pozwól nam pomóc

Nazwa produktu

Sulfanilamide, European Pharmacopoeia (EP) Reference Standard

InChI

1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)

SMILES string

Nc1ccc(cc1)S(N)(=O)=O

InChI key

FDDDEECHVMSUSB-UHFFFAOYSA-N

grade

pharmaceutical primary standard

API family

sulfanilamide

manufacturer/tradename

EDQM

mp

164-166 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-8°C

Szukasz podobnych produktów? Odwiedź Przewodnik dotyczący porównywania produktów

Powiązane kategorie

Porównaj podobne pozycje

Wyświetl pełne porównanie

Pokaż różnice

1 of 4

Ta pozycja
3362616330071632004
Sulfanilamide European Pharmacopoeia (EP) Reference Standard

S2151000

Sulfanilamide

Sulfanilamide puriss. p.a., ≥98% (calc. to the dried substance)

Sigma-Aldrich

33626

Sulfanilamide

Sulfanilamide Melting Point Standard United States Pharmacopeia (USP) Reference Standard

USP

1633007

Sulfanilamide Melting Point Standard

Sulfanilamide United States Pharmacopeia (USP) Reference Standard

USP

1632004

Sulfanilamide

grade

pharmaceutical primary standard

grade

-

grade

pharmaceutical primary standard

grade

pharmaceutical primary standard

manufacturer/tradename

EDQM

manufacturer/tradename

-

manufacturer/tradename

USP

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

application(s)

-

application(s)

pharmaceutical (small molecule)

application(s)

pharmaceutical (small molecule)

format

neat

format

-

format

neat

format

neat

API family

sulfanilamide

API family

-

API family

sulfanilamide

API family

sulfanilamide

mp

164-166 °C (lit.)

mp

163-166 °C, 164-166 °C (lit.)

mp

164-166 °C (lit.)

mp

164-166 °C (lit.)

Application

This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.

General description

Sulfanilamide is an antibacterial drug.[1]
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Ta strona może zawierać tekst przetłumaczony maszynowo.

Klasa składowania

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Wybierz jedną z najnowszych wersji:

Certyfikaty analizy (CoA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumenty section.

Proszę o kontakt, jeśli potrzebna jest pomoc Obsługa Klienta

Masz już ten produkt?

Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.

Odwiedź Bibliotekę dokumentów

SPECTROSCOPIC STUDIES OF CUTANEOUS PHOTOSENSITIZING AGENTS?II. SPIN TRAPPING OF PHOTOLYSIS PRODUCTS FROM SULFANILAMIDE AND 4-AMINOBENZOIC ACID USING 5, 5-DIMETHYL-1-PYRROLINE-1-OXIDE.
Chignell, Colin F., et al.
Photochemistry and Photobiology, 34.2 , 147-156 (1981)
Mohammad Islamuddin et al.
PLoS neglected tropical diseases, 9(1), e3321-e3321 (2015-01-09)
In the absence of vaccines and limitations of currently available chemotherapy, development of safe and efficacious drugs is urgently needed for visceral leishmaniasis (VL) that is fatal, if left untreated. Earlier we reported in vitro apoptotic antileishmanial activity of n-hexane
Danielle D Carrade Holt et al.
Stem cells and development, 23(11), 1258-1265 (2014-01-21)
Mesenchymal stem cells (MSCs) are used in both human clinical trials and veterinary medicine for the treatment of inflammatory and immune-mediated diseases. MSCs modulate inflammation by decreasing the cells and products of the inflammatory response. Stimulated equine MSCs from bone
Mei-Hsiu Chen et al.
Lasers in medical science, 30(1), 263-272 (2014-09-19)
For decades, low-level laser therapy (LLLT) has widespread applications in tendon-related injuries. Although the therapeutic effect of LLLT could be explained by photostimulation of target tissue and cells, how tenocytes sense photonic energy and convert them into cascades of cellular
Guilherme B Bubols et al.
Prenatal diagnosis, 34(13), 1268-1276 (2014-07-22)
Because we have previously demonstrated the relation between polyphenol-rich foods (PRF) consumption and ductus arteriosus constriction, in this work, pregnant sheep were submitted to oral PRF intake for 14 days to understand how this process occurs. Fetal Doppler echocardiography, oxidative and
Wyświetl wszystkie powiązane dokumenty

Questions

Reviews

No rating value

Active Filters

Nasz zespół naukowców ma doświadczenie we wszystkich obszarach badań, w tym w naukach przyrodniczych, materiałoznawstwie, syntezie chemicznej, chromatografii, analityce i wielu innych dziedzinach.

Skontaktuj się z zespołem ds. pomocy technicznej